311
Participants
Start Date
June 30, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
Budesonide / formoterol fumarate (SYMBICORT)
160/4.5 μg x 2 actuations twice daily (bid)
Budesonide
inhalation powder 180 μg x 2 inhalations bid (PULMICORT)
Research Site, Pell City
Research Site, Bentonville
Research Site, Hot Springs
Research Site, Little Rock
Research Site, Malvern
Research Site, Huntington Park
Research Site, Long Beach
Research Site, Los Angeles
Research Site, Los Angles
Research Site, Orange
Research Site, Rolling Hills Estates
Research Site, Centennial
Research Site, Colorado Springs
Research Site, Waterbury
Research Site, Inverness
Research Site, Miami
Research Site, Ocala
Research Site, Tallahassee
Research Site, Tampa
Research Site, Alpharetta
Research Site, Atlanta
Research Site, Decatur
Research Site, Lawrenceville
Research Site, Lithia Springs
Research Site, Lovejoy
Research Site, Chicago
Research Site, Hagerstown
Research Site, Lanham
Research Site, Largo
Research Site, Towson
Research Site, Flint
Research Site, Kansas City
Research Site, St Louis
Research Site, Las Vegas
Research Site, Skillman
Research Site, New York
Research Site, North Syracuse
Research Site, Durham
Research Site, Greenville
Research Site, Raleigh
Research Site, Portland
Research Site, Blue Bell
Research Site, Charleston
Research Site, Spartanburg
Research Site, Memphis
Research Site, Arlington
Research Site, Dallas
Research Site, Fort Worth
Research Site, Houston
Research Site, McKinney
Research Site, Plano
Research Site, San Antonio
Research Site, Waco
Research Site, Emporia
Research Site, Richmond
Research Site, Virginia Beach
Research Site, Milwaukee
Lead Sponsor
AstraZeneca
INDUSTRY